Boenning & Scattergood’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,997	Closed	-$15K	–	281
2018 Q4	$15K	Sell	4,997 -346	-6%	-$1.04K	0.01%	262
2018 Q3	$36K	Buy	5,343 +50	+0.9%	+$337	0.01%	270
2018 Q2	$40K	Buy	+5,293	New	+$40K	0.01%	271